West Pharmaceutical Services, Inc (NYSE: WST) open the trading on Wednesday, with a bit cautious approach as it glided -1.32% to $277.14, before settling in for the price of $280.84 at the close. Taking a more long-term approach, WST posted a 52-week range of $187.43-$348.90.
It was noted that the giant of the Healthcare sector posted annual sales growth of 15.84% over the last 5 years. Meanwhile, its Annual Earning per share during the time was 15.84%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.14%. This publicly-traded company’s shares outstanding now amounts to $71.90 million, simultaneously with a float of $71.50 million. The organization now has a market capitalization sitting at $19.94 billion. At the time of writing, stock’s 50-day Moving Average stood at $270.50, while the 200-day Moving Average is $237.46.
West Pharmaceutical Services, Inc (WST) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Instruments & Supplies industry. West Pharmaceutical Services, Inc’s current insider ownership accounts for 0.62%, in contrast to 97.85% institutional ownership.
West Pharmaceutical Services, Inc (WST) Earnings and Revenue Records
West Pharmaceutical Services, Inc’s EPS increase for this current 12-month fiscal period is 5.14% and is forecasted to reach 7.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 9.25% through the next 5 years, which can be compared against the 15.84% growth it accomplished over the previous five years trading on the market.
West Pharmaceutical Services, Inc (NYSE: WST) Trading Performance Indicators
Let’s observe the current performance indicators for West Pharmaceutical Services, Inc (WST). It’s Quick Ratio in the last reported quarter now stands at 2.18. Alongside those numbers, its PE Ratio stands at $41.05, and its Beta score is 1.16. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.61. Similarly, its price to free cash flow for trailing twelve months is now 52.59.
In the same vein, WST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 6.75, a figure that is expected to reach 1.83 in the next quarter, and analysts are predicting that it will be 7.78 at the market close of one year from today.
Technical Analysis of West Pharmaceutical Services, Inc (WST)
[West Pharmaceutical Services, Inc, WST] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 86.70% While, its Average True Range was 57.30.
Raw Stochastic average of West Pharmaceutical Services, Inc (WST) in the period of the previous 100 days is set at 60.88%, which indicates a major fall in contrast to 83.64% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 7.44 that was higher than 7.12 volatility it exhibited in the past 100-days period.
